International Clinical Trial: Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07737769) titled 'Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome' on July 27.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University of Michigan Rogel Cancer Center

Condition: Acute Myeloid Leukemia Myelodysplastic Syndrome

Intervention: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation Drug: Arsenic Trioxide Procedure: Biospecimen Collection Procedure: Bone Marrow Biopsy Drug: Busulfan...